Min-Han Tan: Lucence’s 7-year journey covered by Forbes Asia
Min-Han Tan, Founding CEO of Lucence, shared a post on LinkedIn:
“Much thanks to Jessica Tan of Forbes Asia for covering the story behind Lucence‘s 7-year journey.
From LiquidHallmark first for my mother in 2017 to Medicare coverage in 2023, and then LucenceInsight today for multi-cancer screening of 50 cancers. The painstaking path to bringing the most carefully tailored blood-testing technology to the world, with the only multi-cancer detection test spanning mutations and HPV.
Wouldn’t have happened without Min-Liang Tan‘s steadfast support at every step along the way.
And so much gratitude to the visionary investors backing us on this – IHH Healthcare, Lim Kaling, Koh Boon Hwee, SGInnovate, Heliconia Capital Management, Openspace and others!”
Read further.
Source: Min-Han Tan/LinkedIn
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023